Gambro continues Southern California expansion

Gambro continues Southern California expansion Stockholm, Sweden - Gambro AB (Stockholm Stock Exchange: GAMBaST, GAMBbST), a leading international medical technology and healthcare company, has acquired the Bentley Dialysis, Inc. center, located in downtown Los Angeles, California. GAMBRO Healthcare, Inc., a subsidiary of Gambro AB, the second largest provider of kidney dialysis services in the United States, announced its acquisition of Bentley Dialysis, Inc. The center is an outpatient renal dialysis clinic with over 135 patients. "We are delighted to announce another addition to the Gambro family. The Bentley acquisition demonstrates our commitment to our growth and restructuring strategy as we strive to become the world's leading provider of high-quality renal care services," said Mats Wahlström, president of GAMBRO Healthcare. The acquired center is owned and operated by GAMBRO Healthcare of California, Inc. All dialysis treatment and related patient services will continue to be administered by the medical directors affiliated with the Brighton Dialysis Associates Medical Group. GAMBRO Healthcare, Inc. is a wholly owned subsidiary of Gambro, AB, a world- leading medical technology and healthcare company. GAMBRO Healthcare is a fully integrated service provider in renal replacement therapy. Its activities include risk contracting, disease management, physician practice management, dialysis services, and clinical laboratory services. GAMBRO Healthcare is the second largest provider of kidney dialysis services in the US. The Company now owns, operates, manages or provides consulting services to 448 dialysis centers in the United States that serve over 34,000 patients. There are patients under treatment in centers across 33 states and the District of Columbia. Several of these centers are associated with prominent academic institutions, such as: @ Duke University @ Emory University @ The Johns Hopkins University Medical School @ Joslin Diabetes Center at Harvard University @ University of Alabama at Birmingham @ University of California at San Diego @ University of Colorado @ University of Miami @ University of Missouri-Kansas City @ University of Oklahoma @ University of Texas/SW Health Systems @ University of Texas/Houston @ The George Washington University Medical School @ Yale University @ For further information please contact: Bengt Modéer, Senior Vice President, Corporate Communications, tel. +46-8-613 65 00, +46-70-513 65 33 Anna Augustson, European Investor Relations Manager, tel. +46-8-613 65 35, +46-70-513 65 34 Tim Schoenberg, Vice President, US Investor Relations Manager, +1-949-425-2185 Gambro is a global medical technology and healthcare company with leading positions in renal care - services and products - and blood component technology (BCT). Gambro is the second largest provider of kidney dialysis services in the world. Gambro treats about 40,000 patients in 460 clinics worldwide. Renal care products comprise dialyzers, dialysis machines, blood lines and dialysis fluid. BCT includes products for the separation and handling of blood components. The Group, with revenue of approximately SEK 19 billion (USD 2.3 billion) has approximately 18,000 employees in some 40 countries. ------------------------------------------------------------ Please visit http://www.bit.se for further information The following files are available for download: http://www.bit.se/bitonline/1999/03/02/19990302BIT00070/bit0001.doc http://www.bit.se/bitonline/1999/03/02/19990302BIT00070/bit0002.pdf